Report Details
Not found what are you looking for
Medical Care
Precision Medicine Market Size, By Technology (Drug Discovery, Big Data Analytics, Gene Sequencing, Other Technologies), By Application (CNS, Immunology, Oncology, Respiratory, Other Applications), By End-Use (Pharmaceutical & Biotechnology Companies, Healthcare Providers, Research Centers & Academic Institutes, Other End uses), By Regional Outlook, Competitive Landscape And Forecast, 2032
Description
ToC
Companies
Speak with Analyst
Market Overview:
Market Introduction
The Global Precision Medicine Market was estimated to be USD 57.7 billion in 2022 and is projected to reach USD 110.9 Billion with a CAGR of 11.5% during the forecast period. Precision medicine is an emerging field within healthcare that tailor’s medical treatments to an individual's unique genetic makeup, environment, and lifestyle. This approach aids medical professionals and scientists in making more precise diagnoses, predicting disease outcomes, and implementing preventive measures. The primary objective of precision medicine, often referred to as customized or tailored medicine, is to target specific genetic mutations that transform normal cells into cancerous ones. Precision medicine treatments, especially in the case of cancer, often result in fewer adverse effects and quicker recoveries compared to standard treatments.
Furthermore, advancements in precision medicine have already led to significant breakthroughs and treatments that have received approval from regulatory bodies like the FDA. These treatments are personalized based on individual characteristics, such as a person's genetic makeup or the genetic profile of a patient's tumor. They hold great promise for the treatment of various diseases. Molecular testing has become a standard part of patient care, particularly for individuals with different types of cancer. This testing allows doctors to choose therapies that not only increase the chances of survival but also reduce the risk of harmful side effects. This personalized approach to treatment is driving the adoption of precision medicine within the healthcare industry.
Key Takeaways:
The swift rise in cancer cases, the growing trend of medical tourism, and the continuous evolution of healthcare technology are significant factors impacting the health industry:
Precision medicine plays a pivotal role in preventing adverse drug reactions and expanding treatment options, thereby stimulating the growth of the medical tourism sector in European countries. As an illustrative example, the United Kingdom government has taken proactive steps by establishing three advanced therapy treatment centers, with an investment of approximately $73.2 million from the Industry Strategy Challenge Fund. This initiative aims to enhance healthcare infrastructure and advance precision medicine and gene therapies.
Furthermore, remarkable technological advancements have significantly propelled the field of precision medicine. Innovations in areas such as genomic sequencing, molecular diagnostics, and data analytics have been instrumental in this growth trajectory. Next-generation sequencing (NGS) technologies, in particular, have revolutionized genomic research, enabling the comprehensive sequencing of entire genomes. This breakthrough allows for the identification of genetic alterations and the detection of biomarkers associated with specific diseases. Moreover, advancements in data analytics and the development of machine learning algorithms have facilitated the integration of diverse datasets, culminating in the generation of actionable insights for personalized treatment decisions. The advent of AI-enabled personalized medicine is poised to grant individuals access to their unique genome, empowering them to receive tailored treatments and protocols aimed at mitigating the consequences of life-altering diseases.
Insufficiency of proficient experts and the elevated expenses linked with precision medicine:
The precision medicine field faces challenges due to the high costs linked to this approach and the shortage of skilled professionals, particularly in developing and underdeveloped nations. The impact of the COVID-19 pandemic and the enforcement of strict regulations have also added constraints to the market's expansion.
A rise in research and development (R&D) endeavors alongside the adoption of cutting-edge technologies:
The expansion of emerging markets, heightened engagement in R&D initiatives, and government programs like the Swiss Personalized Health Network are bolstering market growth. This health network's objective is to advance the field of personalized medicine and healthcare in Switzerland, creating advantageous prospects for market expansion. In August 2020, Sanford Health made a substantial investment of USD 50 million to assist Veteran Affairs (V.A.) physicians in applying precision medicine for more precise medication matching to individual cancer survivors.
The heightened emphasis of manufacturers on the incorporation of cutting-edge technologies such as Next Generation Sequencing (NGS) Tests, molecular diagnostics applications, Cancer genome sequencing, Evidence-based medicine, Molecular medicine, CRISPR, Biomarkers, Biobanking, and Genetic sequencing will continue to create advantageous prospects for the growth of the personalized medicine market throughout the projected period.
Report Coverage:
| Report Details | Outcome |
| Market Size in 2022 | USD 57.69 Billion |
| Revenue CAGR | 11.50% |
| Market Size in 2032 | USD 110.9 Billion |
| Base Year for Estimation | 2022 |
| Historical Data | 2018-2021 |
| Forecast Period | 2023-2032 |
| Segments Covered | Product Type, Application, End Use, and Region |
| Qualitative Info | •Value Chain Analysis •Pricing Analysis •Regional Outlook •Market Trends •Market Share Analysis •Competition Analysis •Technological Advancements |
| Customization Scope | 10 Hours of Free Customization and Expert Consultation |
Technology Outlook:
The drug discovery segment takes the lead in the overall market, commanding a substantial share of 26.1 % during the forecasted period. This dominance is propelled by various factors, including a surge in research and development initiatives by both public and private companies aiming to pioneer novel drugs. Additionally, advances in pharmacogenomics and a growing demand for precision medicine further fuel the growth of this segment. A study published by the National Library of Medicine titled "The Influence of Industrial and Academic Collaboration on Drug Discovery and Development" highlights the success rates of drug discovery and development, revealing figures of about 75% in phase I, 50% in phase II, 59% in phase III, and 88% at the new drug application phase.
Applications Outlook:
oncology segment emerges as the dominant force in the market, capturing a 38.9% share and exhibiting a compelling CAGR of 11.4% in 2022. This can be primarily attributed to the escalating global prevalence of cancer cases. Notably, a survey conducted by Breastcancer.org in July 2020 revealed that out of 534 patients, 33.7% of individuals diagnosed with breast cancer reported significant delays in receiving care. Among these cases, nearly 21.4% experienced delays in screening, while 10.3% encountered treatment delays due to the COVID-19 pandemic in the U.S. The extensive applications of precision medicine in oncology research, coupled with increased funding in cancer research and amplified investments by government organizations in precision medicine software, act as powerful drivers propelling the overall growth of this segment.
End Users Outlook:
The Pharmaceutical and biotechnology Companies segment secures the highest share, accounting for 31.1% and boasting a notable CAGR of 12.1% in 2022. This is attributed to various factors, including the adoption of innovative technologies and the presence of major market players actively engaged in various investment programs. The pharmaceutical industry, as reported in Global Health 2021, is noteworthy for its substantial global spending on research and development, amounting to USD 167 billion. This surpasses the R&D spending of other high-technology industries, with the biopharmaceutical sector outperforming the aerospace and defense industries by 8 times, the chemicals industry by 7.2 times, and the software and computer services industry by 2 times.
Regional Outlook:
North America emerged as the leader in the precision medicine market, commanding a substantial revenue share of 42.4%. This region is poised to maintain its industry leadership during the forecasted period. According to the World Health Organization (WHO), a staggering 41 million deaths are attributed to chronic diseases, with 37.2% of these occurring in North America. Meanwhile, the precision medicine market in Europe is anticipated to witness a commendable CAGR of 9.2% during the forecast period. The European Union has taken proactive steps in developing policies that will usher in the era of precision medicine, advancing healthcare throughout the European region. A significant investment of approximately €2.9 billion has been allocated to fuel innovation and research in precision medicine, driving its growth.
In the Asia-Pacific (APAC) region, a remarkable CAGR of 11.4% is expected during the projected period, with the market reaching a valuation of USD 12.3 Billion in 2023. This exceptional growth can be attributed to various programs and initiatives within the region. Notably, Singapore has taken multiple strides to implement a National Precision Medicine program. The Lee Kong Chian School of Medicine, a part of Nanyang Technological University, has spearheaded the "Health for Life" study, contributing to the advancement of precision medicine in Singapore.
Competitive Landscape:
North America holds a dominant position in the precision medicine market, primarily fueled by substantial investments in precision medicine initiatives across the region. These investments are earmarked for various applications within precision medicine, with a particular emphasis on oncology-targeted therapies. North America is at the forefront of advancements in precision medicine, leading in both its development and implementation. Notable players like Pfizer Inc. and Thermo Fisher Scientific Inc. are key contributors to the region's precision medicine landscape.
Some Leading Market Companies Listed in the Report:
- Pzifer Inc.
- Synapse, Inc.
- Abbott Laboratories
- Healthcare
- Novartis AG
- AB-Biotics SA
- HealthCore, Inc.
- Johnson & Johnson
- Hoffmann-La Roche AG
- Eli Lilly and Company
- Other Key players
Light Engine Industry Recent Developments:
- In November 2022, MedStar Health, in collaboration with Zephyr AI, Inc., announced a partnership aimed at creating AI-enabled precision medicine tools to enhance outcomes for chronic diseases, starting with type 2 diabetes (T2D). This collaboration seeks to augment a Zephyr AI product, known for its predictive analytics capabilities, by leveraging de-identified T2D datasets from MedStar Health and their expertise in patient management. The AI tool is expected to play a pivotal role in enhancing the prospects of T2D interventions while reducing adverse outcomes such as dialysis, chronic kidney disease, foot ulcers, and amputations. This partnership represents a significant stride in utilizing AI and machine learning (ML) to assess the progression of chronic diseases and provide support for chronic disease management.
- In May 2023, Google Cloud forged a strategic alliance with Pfizer and Colossal Biosciences, focusing on leveraging AI tools to advance precision medicine. The collaboration centers around a multiomics suite designed to interpret and discover insights from genomic data, thereby facilitating precision medicine efforts. Additionally, the partnership introduces a target and lead identification suite that employs AI-based data sharing through Google Cloud, catering to various healthcare organizations. AI tools like AlphaFold2 and Vertex AI are instrumental in enabling organizations to predict outcomes and enhance the accuracy of precision medicine practices.
- During the same month of May 2023, Closed Loop Medicine joined forces with Pharmanovia to develop a software version of anti-hypertensive therapy. This innovative Software-as-a-Medical device combines Closed Loop Medicine's expertise with Pharmanovia's anti-hypertensive drug, optimizing patient dosages. As a result, it significantly improves blood pressure control while minimizing the occurrence of side effects, marking a notable advancement in hypertension treatment.
The global Precision medicine market has been segmented based on Technology, Application, End Use, and Region.
Precision Medicine Segment by Technology
- Drug Discovery
- Big Data Analytics
- Gene Sequencing
- Other Technologies
Precision Medicine Segment by Application
- CNS
- Immunology
- Oncology
- Respiratory
- Other Applications
Precision Medicine Segment by End-Use
- Pharmaceutical & Biotechnology Companies
- Healthcare Providers
- Research Centers & Academic Institutes
- Other End uses
Precision Medicine Segment by Region:
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia Pacific
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- South Africa
- Rest of MEA
FAQ
- You should buy this report from Xcellent Insights for a better clarity on market scenarios.
- The market report has been prepared using a pragmatic approach to suit your needs.
- We have an extensive library of reports that can help you understand the market landscape and make informed decisions about your business.
- Additionally, the reports are written by experienced analysts who have a deep understanding of the market and the latest trends.
- Besides, customization is a value-added service if you decide to opt.
Table of Content
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Precision Medicine Market Size Growth Rate by Type: 2018 VS 2022 VS 2032
1.2.2 Diagnostics
1.2.3 Therapies
1.3 Market by Application
1.3.1 Global Precision Medicine Market Share by Application: 2018 VS 2022 VS 2032
1.3.2 Oncology
1.3.3 Neurosciences
1.3.4 Immunology
1.3.5 Respiratory
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Precision Medicine Market Perspective (2018-2032)
2.2 Precision Medicine Growth Trends by Region
2.2.1 Precision Medicine Market Size by Region: 2018 VS 2022 VS 2032
2.2.2 Precision Medicine Historic Market Size by Region (2018-2022)
2.2.3 Precision Medicine Forecasted Market Size by Region (2023-2032)
2.3 Precision Medicine Market Dynamics
2.3.1 Precision Medicine Industry Trends
2.3.2 Precision Medicine Market Drivers
2.3.3 Precision Medicine Market Challenges
2.3.4 Precision Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Precision Medicine Players by Revenue
3.1.1 Global Top Precision Medicine Players by Revenue (2018-2022)
3.1.2 Global Precision Medicine Revenue Market Share by Players (2018-2022)
3.2 Global Precision Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Precision Medicine Revenue
3.4 Global Precision Medicine Market Concentration Ratio
3.4.1 Global Precision Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Precision Medicine Revenue in 2022
3.5 Precision Medicine Key Players Head office and Area Served
3.6 Key Players Precision Medicine Product Solution and Service
3.7 Date of Enter into Precision Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Precision Medicine Breakdown Data by Type
4.1 Global Precision Medicine Historic Market Size by Type (2018-2022)
4.2 Global Precision Medicine Forecasted Market Size by Type (2023-2032)
5 Precision Medicine Breakdown Data by Application
5.1 Global Precision Medicine Historic Market Size by Application (2018-2022)
5.2 Global Precision Medicine Forecasted Market Size by Application (2023-2032)
6 North America
6.1 North America Precision Medicine Market Size (2018-2032)
6.2 North America Precision Medicine Market Size by Country (2018-2022)
6.3 North America Precision Medicine Market Size by Country (2023-2032)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Precision Medicine Market Size (2018-2032)
7.2 Europe Precision Medicine Market Size by Country (2018-2022)
7.3 Europe Precision Medicine Market Size by Country (2023-2032)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Precision Medicine Market Size (2018-2032)
8.2 Asia-Pacific Precision Medicine Market Size by Country (2018-2022)
8.3 Asia-Pacific Precision Medicine Market Size by Country (2023-2032)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Precision Medicine Market Size (2018-2032)
9.2 Latin America Precision Medicine Market Size by Country (2018-2022)
9.3 Latin America Precision Medicine Market Size by Country (2023-2032)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Precision Medicine Market Size (2018-2032)
10.2 Middle East & Africa Precision Medicine Market Size by Country (2018-2022)
10.3 Middle East & Africa Precision Medicine Market Size by Country (2023-2032)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Detail
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Precision Medicine Introduction
11.1.4 Johnson & Johnson Revenue in Precision Medicine Business (2018-2022)
11.1.5 Johnson & Johnson Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche Precision Medicine Introduction
11.2.4 Roche Revenue in Precision Medicine Business (2018-2022)
11.2.5 Roche Recent Development
11.3 Labcorp
11.3.1 Labcorp Company Detail
11.3.2 Labcorp Business Overview
11.3.3 Labcorp Precision Medicine Introduction
11.3.4 Labcorp Revenue in Precision Medicine Business (2018-2022)
11.3.5 Labcorp Recent Development
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Detail
11.4.2 Abbott Laboratories Business Overview
11.4.3 Abbott Laboratories Precision Medicine Introduction
11.4.4 Abbott Laboratories Revenue in Precision Medicine Business (2018-2022)
11.4.5 Abbott Laboratories Recent Development
11.5 Novartis
11.5.1 Novartis Company Detail
11.5.2 Novartis Business Overview
11.5.3 Novartis Precision Medicine Introduction
11.5.4 Novartis Revenue in Precision Medicine Business (2018-2022)
11.5.5 Novartis Recent Development
11.6 Illumina
11.6.1 Illumina Company Detail
11.6.2 Illumina Business Overview
11.6.3 Illumina Precision Medicine Introduction
11.6.4 Illumina Revenue in Precision Medicine Business (2018-2022)
11.6.5 Illumina Recent Development
11.7 GE Healthcare
11.7.1 GE Healthcare Company Detail
11.7.2 GE Healthcare Business Overview
11.7.3 GE Healthcare Precision Medicine Introduction
11.7.4 GE Healthcare Revenue in Precision Medicine Business (2018-2022)
11.7.5 GE Healthcare Recent Development
11.8 Intel Corporation
11.8.1 Intel Corporation Company Detail
11.8.2 Intel Corporation Business Overview
11.8.3 Intel Corporation Precision Medicine Introduction
11.8.4 Intel Corporation Revenue in Precision Medicine Business (2018-2022)
11.8.5 Intel Corporation Recent Development
11.9 Biomrieux Sa
11.9.1 Biomrieux Sa Company Detail
11.9.2 Biomrieux Sa Business Overview
11.9.3 Biomrieux Sa Precision Medicine Introduction
11.9.4 Biomrieux Sa Revenue in Precision Medicine Business (2018-2022)
11.9.5 Biomrieux Sa Recent Development
11.10 Cepheid
11.10.1 Cepheid Company Detail
11.10.2 Cepheid Business Overview
11.10.3 Cepheid Precision Medicine Introduction
11.10.4 Cepheid Revenue in Precision Medicine Business (2018-2022)
11.10.5 Cepheid Recent Development
11.11 IBM
11.11.1 IBM Company Detail
11.11.2 IBM Business Overview
11.11.3 IBM Precision Medicine Introduction
11.11.4 IBM Revenue in Precision Medicine Business (2018-2022)
11.11.5 IBM Recent Development
11.12 Qiagen
11.12.1 Qiagen Company Detail
11.12.2 Qiagen Business Overview
11.12.3 Qiagen Precision Medicine Introduction
11.12.4 Qiagen Revenue in Precision Medicine Business (2018-2022)
11.12.5 Qiagen Recent Development
11.13 Thermo Fisher Scientific
11.13.1 Thermo Fisher Scientific Company Detail
11.13.2 Thermo Fisher Scientific Business Overview
11.13.3 Thermo Fisher Scientific Precision Medicine Introduction
11.13.4 Thermo Fisher Scientific Revenue in Precision Medicine Business (2018-2022)
11.13.5 Thermo Fisher Scientific Recent Development
11.14 Randox Laboratories
11.14.1 Randox Laboratories Company Detail
11.14.2 Randox Laboratories Business Overview
11.14.3 Randox Laboratories Precision Medicine Introduction
11.14.4 Randox Laboratories Revenue in Precision Medicine Business (2018-2022)
11.14.5 Randox Laboratories Recent Development
11.15 Almac Group
11.15.1 Almac Group Company Detail
11.15.2 Almac Group Business Overview
11.15.3 Almac Group Precision Medicine Introduction
11.15.4 Almac Group Revenue in Precision Medicine Business (2018-2022)
11.15.5 Almac Group Recent Development
11.16 Healthcore
11.16.1 Healthcore Company Detail
11.16.2 Healthcore Business Overview
11.16.3 Healthcore Precision Medicine Introduction
11.16.4 Healthcore Revenue in Precision Medicine Business (2018-2022)
11.16.5 Healthcore Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Tables and Figures
List of Tables
Table 1. Global Precision Medicine Market Size Growth Rate by Type (US$ Million): 2018 VS 2023 VS 2032
Table 2. Key Players of Diagnostics
Table 3. Key Players of Therapies
Table 4. Global Precision Medicine Market Size Growth by Application (US$ Million): 2018 VS 2023 VS 2032
Table 5. Global Precision Medicine Market Size by Region (US$ Million): 2018 VS 2023 VS 2032
Table 6. Global Precision Medicine Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Precision Medicine Market Share by Region (2018-2023)
Table 8. Global Precision Medicine Forecasted Market Size by Region (2023-2032) & (US$ Million)
Table 9. Global Precision Medicine Market Share by Region (2023-2032)
Table 10. Precision Medicine Market Trends
Table 11. Precision Medicine Market Drivers
Table 12. Precision Medicine Market Challenges
Table 13. Precision Medicine Market Restraints
Table 14. Global Precision Medicine Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Precision Medicine Market Share by Players (2018-2023)
Table 16. Global Top Precision Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Medicine as of 2021)
Table 17. Ranking of Global Top Precision Medicine Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Precision Medicine Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Precision Medicine Product Solution and Service
Table 21. Date of Enter into Precision Medicine Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Precision Medicine Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Precision Medicine Revenue Market Share by Type (2018-2023)
Table 25. Global Precision Medicine Forecasted Market Size by Type (2023-2032) & (US$ Million)
Table 26. Global Precision Medicine Revenue Market Share by Type (2023-2032)
Table 27. Global Precision Medicine Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Precision Medicine Revenue Market Share by Application (2018-2023)
Table 29. Global Precision Medicine Forecasted Market Size by Application (2023-2032) & (US$ Million)
Table 30. Global Precision Medicine Revenue Market Share by Application (2023-2032)
Table 31. North America Precision Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Precision Medicine Market Size by Country (2023-2032) & (US$ Million)
Table 33. Europe Precision Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 34. Europe Precision Medicine Market Size by Country (2023-2032) & (US$ Million)
Table 35. Asia-Pacific Precision Medicine Market Size by Region (2018-2023) & (US$ Million)
Table 36. Asia-Pacific Precision Medicine Market Size by Region (2023-2032) & (US$ Million)
Table 37. Latin America Precision Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 38. Latin America Precision Medicine Market Size by Country (2023-2032) & (US$ Million)
Table 39. Middle East & Africa Precision Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 40. Middle East & Africa Precision Medicine Market Size by Country (2023-2032) & (US$ Million)
Table 41. Johnson & Johnson Company Detail
Table 42. Johnson & Johnson Business Overview
Table 43. Johnson & Johnson Precision Medicine Product
Table 44. Johnson & Johnson Revenue in Precision Medicine Business (2018-2023) & (US$ Million)
Table 45. Johnson & Johnson Recent Development
Table 46. Roche Company Detail
Table 47. Roche Business Overview
Table 48. Roche Precision Medicine Product
Table 49. Roche Revenue in Precision Medicine Business (2018-2023) & (US$ Million)
Table 50. Roche Recent Development
Table 51. Labcorp Company Detail
Table 52. Labcorp Business Overview
Table 53. Labcorp Precision Medicine Product
Table 54. Labcorp Revenue in Precision Medicine Business (2018-2023) & (US$ Million)
Table 55. Labcorp Recent Development
Table 56. Abbott Laboratories Company Detail
Table 57. Abbott Laboratories Business Overview
Table 58. Abbott Laboratories Precision Medicine Product
Table 59. Abbott Laboratories Revenue in Precision Medicine Business (2018-2023) & (US$ Million)
Table 60. Abbott Laboratories Recent Development
Table 61. Novartis Company Detail
Table 62. Novartis Business Overview
Table 63. Novartis Precision Medicine Product
Table 64. Novartis Revenue in Precision Medicine Business (2018-2023) & (US$ Million)
Table 65. Novartis Recent Development
Table 66. Illumina Company Detail
Table 67. Illumina Business Overview
Table 68. Illumina Precision Medicine Product
Table 69. Illumina Revenue in Precision Medicine Business (2018-2023) & (US$ Million)
Table 70. Illumina Recent Development
Table 71. GE Healthcare Company Detail
Table 72. GE Healthcare Business Overview
Table 73. GE Healthcare Precision Medicine Product
Table 74. GE Healthcare Revenue in Precision Medicine Business (2018-2023) & (US$ Million)
Table 75. GE Healthcare Recent Development
Table 76. Intel Corporation Company Detail
Table 77. Intel Corporation Business Overview
Table 78. Intel Corporation Precision Medicine Product
Table 79. Intel Corporation Revenue in Precision Medicine Business (2018-2023) & (US$ Million)
Table 80. Intel Corporation Recent Development
Table 81. Biomrieux Sa Company Detail
Table 82. Biomrieux Sa Business Overview
Table 83. Biomrieux Sa Precision Medicine Product
Table 84. Biomrieux Sa Revenue in Precision Medicine Business (2018-2023) & (US$ Million)
Table 85. Biomrieux Sa Recent Development
Table 86. Cepheid Company Detail
Table 87. Cepheid Business Overview
Table 88. Cepheid Precision Medicine Product
Table 89. Cepheid Revenue in Precision Medicine Business (2018-2023) & (US$ Million)
Table 90. Cepheid Recent Development
Table 91. IBM Company Detail
Table 92. IBM Business Overview
Table 93. IBM Precision MedicineProduct
Table 94. IBM Revenue in Precision Medicine Business (2018-2023) & (US$ Million)
Table 95. IBM Recent Development
Table 96. Qiagen Company Detail
Table 97. Qiagen Business Overview
Table 98. Qiagen Precision MedicineProduct
Table 99. Qiagen Revenue in Precision Medicine Business (2018-2023) & (US$ Million)
Table 100. Qiagen Recent Development
Table 101. Thermo Fisher Scientific Company Detail
Table 102. Thermo Fisher Scientific Business Overview
Table 103. Thermo Fisher Scientific Precision MedicineProduct
Table 104. Thermo Fisher Scientific Revenue in Precision Medicine Business (2018-2023) & (US$ Million)
Table 105. Thermo Fisher Scientific Recent Development
Table 106. Randox Laboratories Company Detail
Table 107. Randox Laboratories Business Overview
Table 108. Randox Laboratories Precision MedicineProduct
Table 109. Randox Laboratories Revenue in Precision Medicine Business (2018-2023) & (US$ Million)
Table 110. Randox Laboratories Recent Development
Table 111. Almac Group Company Detail
Table 112. Almac Group Business Overview
Table 113. Almac Group Precision MedicineProduct
Table 114. Almac Group Revenue in Precision Medicine Business (2018-2023) & (US$ Million)
Table 115. Almac Group Recent Development
Table 116. Healthcore Company Detail
Table 117. Healthcore Business Overview
Table 118. Healthcore Precision MedicineProduct
Table 119. Healthcore Revenue in Precision Medicine Business (2018-2023) & (US$ Million)
Table 120. Healthcore Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Precision Medicine Market Share by Type: 2022 VS 2032
Figure 2. Diagnostics Features
Figure 3. Therapies Features
Figure 4. Global Precision Medicine Market Share by Application in 2021 & 2028
Figure 5. Oncology Case Studies
Figure 6. Neurosciences Case Studies
Figure 7. Immunology Case Studies
Figure 8. Respiratory Case Studies
Figure 9. Others Case Studies
Figure 10. Precision Medicine Report Years Considered
Figure 11. Global Precision Medicine Market Size (US$ Million), Year-over-Year: 2018-2032
Figure 12. Global Precision Medicine Market Size, (US$ Million), 2018 VS 2023 VS 2032
Figure 13. Global Precision Medicine Market Share by Region: 2022 VS 2032
Figure 14. Global Precision Medicine Market Share by Players in 2021
Figure 15. Global Top Precision Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Medicine as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Precision Medicine Revenue in 2021
Figure 17. North America Precision Medicine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 18. North America Precision Medicine Market Share by Country (2018-2032)
Figure 19. United States Precision Medicine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 20. Canada Precision Medicine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 21. Europe Precision Medicine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 22. Europe Precision Medicine Market Share by Country (2018-2032)
Figure 23. Germany Precision Medicine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 24. France Precision Medicine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 25. U.K. Precision Medicine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 26. Italy Precision Medicine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 27. Russia Precision Medicine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 28. Nordic Countries Precision Medicine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 29. Asia-Pacific Precision Medicine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 30. Asia-Pacific Precision Medicine Market Share by Region (2018-2032)
Figure 31. China Precision Medicine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 32. Japan Precision Medicine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 33. South Korea Precision Medicine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 34. Southeast Asia Precision Medicine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 35. India Precision Medicine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 36. Australia Precision Medicine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 37. Latin America Precision Medicine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 38. Latin America Precision Medicine Market Share by Country (2018-2032)
Figure 39. Mexico Precision Medicine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 40. Brazil Precision Medicine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 41. Middle East & Africa Precision Medicine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 42. Middle East & Africa Precision Medicine Market Share by Country (2018-2032)
Figure 43. Turkey Precision Medicine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 44. Saudi Arabia Precision Medicine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 45. Johnson & Johnson Revenue Growth Rate in Precision Medicine Business (2018-2023)
Figure 46. Roche Revenue Growth Rate in Precision Medicine Business (2018-2023)
Figure 47. Labcorp Revenue Growth Rate in Precision Medicine Business (2018-2023)
Figure 48. Abbott Laboratories Revenue Growth Rate in Precision Medicine Business (2018-2023)
Figure 49. Novartis Revenue Growth Rate in Precision Medicine Business (2018-2023)
Figure 50. Illumina Revenue Growth Rate in Precision Medicine Business (2018-2023)
Figure 51. GE Healthcare Revenue Growth Rate in Precision Medicine Business (2018-2023)
Figure 52. Intel Corporation Revenue Growth Rate in Precision Medicine Business (2018-2023)
Figure 53. Biomrieux Sa Revenue Growth Rate in Precision Medicine Business (2018-2023)
Figure 54. Cepheid Revenue Growth Rate in Precision Medicine Business (2018-2023)
Figure 55. IBM Revenue Growth Rate in Precision Medicine Business (2018-2023)
Figure 56. Qiagen Revenue Growth Rate in Precision Medicine Business (2018-2023)
Figure 57. Thermo Fisher Scientific Revenue Growth Rate in Precision Medicine Business (2018-2023)
Figure 58. Randox Laboratories Revenue Growth Rate in Precision Medicine Business (2018-2023)
Figure 59. Almac Group Revenue Growth Rate in Precision Medicine Business (2018-2023)
Figure 60. Healthcore Revenue Growth Rate in Precision Medicine Business (2018-2023)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Key Players
- Johnson & Johnson
- Roche
- Labcorp
- Abbott Laboratories
- Novartis
- Illumina
- GE Healthcare
- Intel Corporation
- Biomrieux Sa
- Cepheid
- IBM
- Qiagen
- Thermo Fisher Scientific
- Randox Laboratories
- Almac Group
- Healthcore
Why Choose Us
- Extensive Library of Reports.
- Identify the clients' needs.
- Pragmatic Research Approach.
- Clarity on Market Scenarios.
- Tailor-Made Solutions.
- Expert Analysts Team.
- Competitive and Fair Prices.
Clientele
Thank you
Xcellent Insights has received your query!